Blue Trust Inc’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$216K Buy
2,730
+245
+10% +$20.8K ﹤0.01% 763
2026
Q1
$214K Buy
+2,485
New +$223K ﹤0.01% 752
2024
Q4
Sell
-216
Closed -$14.8K 2651
2024
Q3
$14.8K Buy
216
+61
+39% +$4.31K ﹤0.01% 2062
2024
Q2
$8.31K Buy
155
+18
+13% +$1.07K ﹤0.01% 2004
2024
Q1
$7.35K Buy
137
+30
+28% +$1.61K ﹤0.01% 1535
2023
Q4
$5K Sell
107
-55
-34% -$2.68K ﹤0.01% 1834
2023
Q3
$10K Buy
162
+73
+82% +$4.08K ﹤0.01% 1408
2023
Q2
$5K Sell
89
-437
-83% -$24.9K ﹤0.01% 1526
2023
Q1
$39K Buy
526
+76
+17% +$4.87K ﹤0.01% 1124
2022
Q4
$27K Buy
450
+277
+160% +$18.9K ﹤0.01% 1175
2022
Q3
$10K Buy
173
+59
+52% +$3.55K ﹤0.01% 1332
2022
Q2
$8K Buy
+114
New +$7.49K ﹤0.01% 1280

Other funds holding GMED

Blue Trust Inc's GMED Position: Q2 2026 in Review

Blue Trust Inc increased its Globus Medical (GMED) stake by 9.9% in Q2 2026, buying an estimated $20.8K and bringing the position to 2,730 shares worth $216K. The position accounts for ﹤0.01% of the portfolio, ranked #763.

Blue Trust Inc first reported a position in GMED in Q2 2022 and has held it in 12 quarters since. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Blue Trust Inc held 2,730 shares of Globus Medical worth $216K as of Q2 2026.
  • Blue Trust Inc bought 245 Globus Medical shares in Q2 2026, an estimated $20.8K.
  • Globus Medical made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #763 holding.
  • Blue Trust Inc first reported a position in Globus Medical in Q2 2022 and has held it in 12 quarters since.
  • 599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.